Global Tumor Immunotherapy Market Growth (Status and Outlook) 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Tumor Immunotherapy Market Size 2017-2028

2.1.2 Tumor Immunotherapy Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Tumor Immunotherapy Segment by Type

2.2.1 Tumor Infiltrating Lymphocyte (TIL) Treatment

2.2.2 Engineered T Cell Receptor (TCR) Therapy

2.2.3 Chimeric Antigen Receptor (CAR) T Cell Therapy

2.2.4 Natural Killer (NK) Cell Therapy

2.2.5 Other

2.3 Tumor Immunotherapy Market Size by Type

2.3.1 Tumor Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Tumor Immunotherapy Market Size Market Share by Type (2017-2022)

2.4 Tumor Immunotherapy Segment by Application

2.4.1 Biopharmaceutical Company

2.4.2 Hospital

2.4.3 Universities And Other Scientific Research Institutions

2.4.4 Other

2.5 Tumor Immunotherapy Market Size by Application

2.5.1 Tumor Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Tumor Immunotherapy Market Size Market Share by Application (2017-2022)

3 Tumor Immunotherapy Market Size by Player

3.1 Tumor Immunotherapy Market Size Market Share by Players

3.1.1 Global Tumor Immunotherapy Revenue by Players (2020-2022)

3.1.2 Global Tumor Immunotherapy Revenue Market Share by Players (2020-2022)

3.2 Global Tumor Immunotherapy Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Tumor Immunotherapy by Regions

4.1 Tumor Immunotherapy Market Size by Regions (2017-2022)

4.2 Americas Tumor Immunotherapy Market Size Growth (2017-2022)

4.3 APAC Tumor Immunotherapy Market Size Growth (2017-2022)

4.4 Europe Tumor Immunotherapy Market Size Growth (2017-2022)

4.5 Middle East & Africa Tumor Immunotherapy Market Size Growth (2017-2022)

5 Americas

5.1 Americas Tumor Immunotherapy Market Size by Country (2017-2022)

5.2 Americas Tumor Immunotherapy Market Size by Type (2017-2022)

5.3 Americas Tumor Immunotherapy Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Tumor Immunotherapy Market Size by Region (2017-2022)

6.2 APAC Tumor Immunotherapy Market Size by Type (2017-2022)

6.3 APAC Tumor Immunotherapy Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Tumor Immunotherapy by Country (2017-2022)

7.2 Europe Tumor Immunotherapy Market Size by Type (2017-2022)

7.3 Europe Tumor Immunotherapy Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Tumor Immunotherapy by Region (2017-2022)

8.2 Middle East & Africa Tumor Immunotherapy Market Size by Type (2017-2022)

8.3 Middle East & Africa Tumor Immunotherapy Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Tumor Immunotherapy Market Forecast

10.1 Global Tumor Immunotherapy Forecast by Regions (2023-2028)

10.1.1 Global Tumor Immunotherapy Forecast by Regions (2023-2028)

10.1.2 Americas Tumor Immunotherapy Forecast

10.1.3 APAC Tumor Immunotherapy Forecast

10.1.4 Europe Tumor Immunotherapy Forecast

10.1.5 Middle East & Africa Tumor Immunotherapy Forecast

10.2 Americas Tumor Immunotherapy Forecast by Country (2023-2028)

10.2.1 United States Tumor Immunotherapy Market Forecast

10.2.2 Canada Tumor Immunotherapy Market Forecast

10.2.3 Mexico Tumor Immunotherapy Market Forecast

10.2.4 Brazil Tumor Immunotherapy Market Forecast

10.3 APAC Tumor Immunotherapy Forecast by Region (2023-2028)

10.3.1 China Tumor Immunotherapy Market Forecast

10.3.2 Japan Tumor Immunotherapy Market Forecast

10.3.3 Korea Tumor Immunotherapy Market Forecast

10.3.4 Southeast Asia Tumor Immunotherapy Market Forecast

10.3.5 India Tumor Immunotherapy Market Forecast

10.3.6 Australia Tumor Immunotherapy Market Forecast

10.4 Europe Tumor Immunotherapy Forecast by Country (2023-2028)

10.4.1 Germany Tumor Immunotherapy Market Forecast

10.4.2 France Tumor Immunotherapy Market Forecast

10.4.3 UK Tumor Immunotherapy Market Forecast

10.4.4 Italy Tumor Immunotherapy Market Forecast

10.4.5 Russia Tumor Immunotherapy Market Forecast

10.5 Middle East & Africa Tumor Immunotherapy Forecast by Region (2023-2028)

10.5.1 Egypt Tumor Immunotherapy Market Forecast

10.5.2 South Africa Tumor Immunotherapy Market Forecast

10.5.3 Israel Tumor Immunotherapy Market Forecast

10.5.4 Turkey Tumor Immunotherapy Market Forecast

10.5.5 GCC Countries Tumor Immunotherapy Market Forecast

10.6 Global Tumor Immunotherapy Forecast by Type (2023-2028)

10.7 Global Tumor Immunotherapy Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Roche

11.1.1 Roche Company Information

11.1.2 Roche Tumor Immunotherapy Product Offered

11.1.3 Roche Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Roche Main Business Overview

11.1.5 Roche Latest Developments

11.2 Merck

11.2.1 Merck Company Information

11.2.2 Merck Tumor Immunotherapy Product Offered

11.2.3 Merck Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Merck Main Business Overview

11.2.5 Merck Latest Developments

11.3 Novartis

11.3.1 Novartis Company Information

11.3.2 Novartis Tumor Immunotherapy Product Offered

11.3.3 Novartis Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Novartis Main Business Overview

11.3.5 Novartis Latest Developments

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Information

11.4.2 Johnson & Johnson Tumor Immunotherapy Product Offered

11.4.3 Johnson & Johnson Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 Johnson & Johnson Main Business Overview

11.4.5 Johnson & Johnson Latest Developments

11.5 GlaxoSmithKline

11.5.1 GlaxoSmithKline Company Information

11.5.2 GlaxoSmithKline Tumor Immunotherapy Product Offered

11.5.3 GlaxoSmithKline Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 GlaxoSmithKline Main Business Overview

11.5.5 GlaxoSmithKline Latest Developments

11.6 AbbVie

11.6.1 AbbVie Company Information

11.6.2 AbbVie Tumor Immunotherapy Product Offered

11.6.3 AbbVie Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 AbbVie Main Business Overview

11.6.5 AbbVie Latest Developments

11.7 ELI Lilly

11.7.1 ELI Lilly Company Information

11.7.2 ELI Lilly Tumor Immunotherapy Product Offered

11.7.3 ELI Lilly Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 ELI Lilly Main Business Overview

11.7.5 ELI Lilly Latest Developments

11.8 Amgen

11.8.1 Amgen Company Information

11.8.2 Amgen Tumor Immunotherapy Product Offered

11.8.3 Amgen Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Amgen Main Business Overview

11.8.5 Amgen Latest Developments

11.9 AstraZeneca

11.9.1 AstraZeneca Company Information

11.9.2 AstraZeneca Tumor Immunotherapy Product Offered

11.9.3 AstraZeneca Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 AstraZeneca Main Business Overview

11.9.5 AstraZeneca Latest Developments

11.10 Bristol-Mysers Squibb

11.10.1 Bristol-Mysers Squibb Company Information

11.10.2 Bristol-Mysers Squibb Tumor Immunotherapy Product Offered

11.10.3 Bristol-Mysers Squibb Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 Bristol-Mysers Squibb Main Business Overview

11.10.5 Bristol-Mysers Squibb Latest Developments

11.11 Kite Pharma

11.11.1 Kite Pharma Company Information

11.11.2 Kite Pharma Tumor Immunotherapy Product Offered

11.11.3 Kite Pharma Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Kite Pharma Main Business Overview

11.11.5 Kite Pharma Latest Developments

11.12 Adaptimmune

11.12.1 Adaptimmune Company Information

11.12.2 Adaptimmune Tumor Immunotherapy Product Offered

11.12.3 Adaptimmune Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 Adaptimmune Main Business Overview

11.12.5 Adaptimmune Latest Developments

11.13 Altor Bioscience Corporation

11.13.1 Altor Bioscience Corporation Company Information

11.13.2 Altor Bioscience Corporation Tumor Immunotherapy Product Offered

11.13.3 Altor Bioscience Corporation Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Altor Bioscience Corporation Main Business Overview

11.13.5 Altor Bioscience Corporation Latest Developments

11.14 Cellectis

11.14.1 Cellectis Company Information

11.14.2 Cellectis Tumor Immunotherapy Product Offered

11.14.3 Cellectis Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Cellectis Main Business Overview

11.14.5 Cellectis Latest Developments

11.15 Juno Therapeutics

11.15.1 Juno Therapeutics Company Information

11.15.2 Juno Therapeutics Tumor Immunotherapy Product Offered

11.15.3 Juno Therapeutics Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Juno Therapeutics Main Business Overview

11.15.5 Juno Therapeutics Latest Developments

11.16 Takara Bio

11.16.1 Takara Bio Company Information

11.16.2 Takara Bio Tumor Immunotherapy Product Offered

11.16.3 Takara Bio Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Takara Bio Main Business Overview

11.16.5 Takara Bio Latest Developments

11.17 Unum Therapeutics

11.17.1 Unum Therapeutics Company Information

11.17.2 Unum Therapeutics Tumor Immunotherapy Product Offered

11.17.3 Unum Therapeutics Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.17.4 Unum Therapeutics Main Business Overview

11.17.5 Unum Therapeutics Latest Developments

11.18 Sunway

11.18.1 Sunway Company Information

11.18.2 Sunway Tumor Immunotherapy Product Offered

11.18.3 Sunway Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.18.4 Sunway Main Business Overview

11.18.5 Sunway Latest Developments

11.19 Junshi Bio

11.19.1 Junshi Bio Company Information

11.19.2 Junshi Bio Tumor Immunotherapy Product Offered

11.19.3 Junshi Bio Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.19.4 Junshi Bio Main Business Overview

11.19.5 Junshi Bio Latest Developments

11.20 Cinda Bio

11.20.1 Cinda Bio Company Information

11.20.2 Cinda Bio Tumor Immunotherapy Product Offered

11.20.3 Cinda Bio Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.20.4 Cinda Bio Main Business Overview

11.20.5 Cinda Bio Latest Developments

11.21 BeiGene

11.21.1 BeiGene Company Information

11.21.2 BeiGene Tumor Immunotherapy Product Offered

11.21.3 BeiGene Tumor Immunotherapy Revenue, Gross Margin and Market Share (2020-2022)

11.21.4 BeiGene Main Business Overview

11.21.5 BeiGene Latest Developments

12 Research Findings and Conclusion

Table 1. Tumor Immunotherapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Tumor Infiltrating Lymphocyte (TIL) Treatment

Table 3. Major Players of Engineered T Cell Receptor (TCR) Therapy

Table 4. Major Players of Chimeric Antigen Receptor (CAR) T Cell Therapy

Table 5. Major Players of Natural Killer (NK) Cell Therapy

Table 6. Major Players of Other

Table 7. Tumor Immunotherapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Tumor Immunotherapy Market Size by Type (2017-2022) & ($ Millions)

Table 9. Global Tumor Immunotherapy Market Size Market Share by Type (2017-2022)

Table 10. Tumor Immunotherapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 11. Global Tumor Immunotherapy Market Size by Application (2017-2022) & ($ Millions)

Table 12. Global Tumor Immunotherapy Market Size Market Share by Application (2017-2022)

Table 13. Global Tumor Immunotherapy Revenue by Players (2020-2022) & ($ Millions)

Table 14. Global Tumor Immunotherapy Revenue Market Share by Player (2020-2022)

Table 15. Tumor Immunotherapy Key Players Head office and Products Offered

Table 16. Tumor Immunotherapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 17. New Products and Potential Entrants

Table 18. Mergers & Acquisitions, Expansion

Table 19. Global Tumor Immunotherapy Market Size by Regions 2017-2022 & ($ Millions)

Table 20. Global Tumor Immunotherapy Market Size Market Share by Regions (2017-2022)

Table 21. Americas Tumor Immunotherapy Market Size by Country (2017-2022) & ($ Millions)

Table 22. Americas Tumor Immunotherapy Market Size Market Share by Country (2017-2022)

Table 23. Americas Tumor Immunotherapy Market Size by Type (2017-2022) & ($ Millions)

Table 24. Americas Tumor Immunotherapy Market Size Market Share by Type (2017-2022)

Table 25. Americas Tumor Immunotherapy Market Size by Application (2017-2022) & ($ Millions)

Table 26. Americas Tumor Immunotherapy Market Size Market Share by Application (2017-2022)

Table 27. APAC Tumor Immunotherapy Market Size by Region (2017-2022) & ($ Millions)

Table 28. APAC Tumor Immunotherapy Market Size Market Share by Region (2017-2022)

Table 29. APAC Tumor Immunotherapy Market Size by Type (2017-2022) & ($ Millions)

Table 30. APAC Tumor Immunotherapy Market Size Market Share by Type (2017-2022)

Table 31. APAC Tumor Immunotherapy Market Size by Application (2017-2022) & ($ Millions)

Table 32. APAC Tumor Immunotherapy Market Size Market Share by Application (2017-2022)

Table 33. Europe Tumor Immunotherapy Market Size by Country (2017-2022) & ($ Millions)

Table 34. Europe Tumor Immunotherapy Market Size Market Share by Country (2017-2022)

Table 35. Europe Tumor Immunotherapy Market Size by Type (2017-2022) & ($ Millions)

Table 36. Europe Tumor Immunotherapy Market Size Market Share by Type (2017-2022)

Table 37. Europe Tumor Immunotherapy Market Size by Application (2017-2022) & ($ Millions)

Table 38. Europe Tumor Immunotherapy Market Size Market Share by Application (2017-2022)

Table 39. Middle East & Africa Tumor Immunotherapy Market Size by Region (2017-2022) & ($ Millions)

Table 40. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Region (2017-2022)

Table 41. Middle East & Africa Tumor Immunotherapy Market Size by Type (2017-2022) & ($ Millions)

Table 42. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Type (2017-2022)

Table 43. Middle East & Africa Tumor Immunotherapy Market Size by Application (2017-2022) & ($ Millions)

Table 44. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Application (2017-2022)

Table 45. Key Market Drivers & Growth Opportunities of Tumor Immunotherapy

Table 46. Key Market Challenges & Risks of Tumor Immunotherapy

Table 47. Key Industry Trends of Tumor Immunotherapy

Table 48. Global Tumor Immunotherapy Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 49. Global Tumor Immunotherapy Market Size Market Share Forecast by Regions (2023-2028)

Table 50. Global Tumor Immunotherapy Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 51. Global Tumor Immunotherapy Market Size Market Share Forecast by Type (2023-2028)

Table 52. Global Tumor Immunotherapy Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 53. Global Tumor Immunotherapy Market Size Market Share Forecast by Application (2023-2028)

Table 54. Roche Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 55. Roche Tumor Immunotherapy Product Offered

Table 56. Roche Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 57. Roche Main Business

Table 58. Roche Latest Developments

Table 59. Merck Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 60. Merck Tumor Immunotherapy Product Offered

Table 61. Merck Main Business

Table 62. Merck Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 63. Merck Latest Developments

Table 64. Novartis Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 65. Novartis Tumor Immunotherapy Product Offered

Table 66. Novartis Main Business

Table 67. Novartis Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 68. Novartis Latest Developments

Table 69. Johnson & Johnson Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 70. Johnson & Johnson Tumor Immunotherapy Product Offered

Table 71. Johnson & Johnson Main Business

Table 72. Johnson & Johnson Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 73. Johnson & Johnson Latest Developments

Table 74. GlaxoSmithKline Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 75. GlaxoSmithKline Tumor Immunotherapy Product Offered

Table 76. GlaxoSmithKline Main Business

Table 77. GlaxoSmithKline Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 78. GlaxoSmithKline Latest Developments

Table 79. AbbVie Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 80. AbbVie Tumor Immunotherapy Product Offered

Table 81. AbbVie Main Business

Table 82. AbbVie Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 83. AbbVie Latest Developments

Table 84. ELI Lilly Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 85. ELI Lilly Tumor Immunotherapy Product Offered

Table 86. ELI Lilly Main Business

Table 87. ELI Lilly Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 88. ELI Lilly Latest Developments

Table 89. Amgen Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 90. Amgen Tumor Immunotherapy Product Offered

Table 91. Amgen Main Business

Table 92. Amgen Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 93. Amgen Latest Developments

Table 94. AstraZeneca Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 95. AstraZeneca Tumor Immunotherapy Product Offered

Table 96. AstraZeneca Main Business

Table 97. AstraZeneca Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 98. AstraZeneca Latest Developments

Table 99. Bristol-Mysers Squibb Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 100. Bristol-Mysers Squibb Tumor Immunotherapy Product Offered

Table 101. Bristol-Mysers Squibb Main Business

Table 102. Bristol-Mysers Squibb Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 103. Bristol-Mysers Squibb Latest Developments

Table 104. Kite Pharma Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 105. Kite Pharma Tumor Immunotherapy Product Offered

Table 106. Kite Pharma Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 107. Kite Pharma Main Business

Table 108. Kite Pharma Latest Developments

Table 109. Adaptimmune Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 110. Adaptimmune Tumor Immunotherapy Product Offered

Table 111. Adaptimmune Main Business

Table 112. Adaptimmune Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 113. Adaptimmune Latest Developments

Table 114. Altor Bioscience Corporation Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 115. Altor Bioscience Corporation Tumor Immunotherapy Product Offered

Table 116. Altor Bioscience Corporation Main Business

Table 117. Altor Bioscience Corporation Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 118. Altor Bioscience Corporation Latest Developments

Table 119. Cellectis Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 120. Cellectis Tumor Immunotherapy Product Offered

Table 121. Cellectis Main Business

Table 122. Cellectis Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 123. Cellectis Latest Developments

Table 124. Juno Therapeutics Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 125. Juno Therapeutics Tumor Immunotherapy Product Offered

Table 126. Juno Therapeutics Main Business

Table 127. Juno Therapeutics Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 128. Juno Therapeutics Latest Developments

Table 129. Takara Bio Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 130. Takara Bio Tumor Immunotherapy Product Offered

Table 131. Takara Bio Main Business

Table 132. Takara Bio Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 133. Takara Bio Latest Developments

Table 134. Unum Therapeutics Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 135. Unum Therapeutics Tumor Immunotherapy Product Offered

Table 136. Unum Therapeutics Main Business

Table 137. Unum Therapeutics Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 138. Unum Therapeutics Latest Developments

Table 139. Sunway Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 140. Sunway Tumor Immunotherapy Product Offered

Table 141. Sunway Main Business

Table 142. Sunway Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 143. Sunway Latest Developments

Table 144. Junshi Bio Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 145. Junshi Bio Tumor Immunotherapy Product Offered

Table 146. Junshi Bio Main Business

Table 147. Junshi Bio Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 148. Junshi Bio Latest Developments

Table 149. Cinda Bio Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 150. Cinda Bio Tumor Immunotherapy Product Offered

Table 151. Cinda Bio Main Business

Table 152. Cinda Bio Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 153. Cinda Bio Latest Developments

Table 154. BeiGene Details, Company Type, Tumor Immunotherapy Area Served and Its Competitors

Table 155. BeiGene Tumor Immunotherapy Product Offered

Table 156. BeiGene Tumor Immunotherapy Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 157. BeiGene Main Business

Table 158. BeiGene Latest Developments

List of Figures

Figure 1. Tumor Immunotherapy Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Tumor Immunotherapy Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Tumor Immunotherapy Market Size Market Share by Type in 2021

Figure 7. Tumor Immunotherapy in Biopharmaceutical Company

Figure 8. Global Tumor Immunotherapy Market: Biopharmaceutical Company (2017-2022) & ($ Millions)

Figure 9. Tumor Immunotherapy in Hospital

Figure 10. Global Tumor Immunotherapy Market: Hospital (2017-2022) & ($ Millions)

Figure 11. Tumor Immunotherapy in Universities And Other Scientific Research Institutions

Figure 12. Global Tumor Immunotherapy Market: Universities And Other Scientific Research Institutions (2017-2022) & ($ Millions)

Figure 13. Tumor Immunotherapy in Other

Figure 14. Global Tumor Immunotherapy Market: Other (2017-2022) & ($ Millions)

Figure 15. Global Tumor Immunotherapy Market Size Market Share by Application in 2021

Figure 16. Global Tumor Immunotherapy Revenue Market Share by Player in 2021

Figure 17. Global Tumor Immunotherapy Market Size Market Share by Regions (2017-2022)

Figure 18. Americas Tumor Immunotherapy Market Size 2017-2022 ($ Millions)

Figure 19. APAC Tumor Immunotherapy Market Size 2017-2022 ($ Millions)

Figure 20. Europe Tumor Immunotherapy Market Size 2017-2022 ($ Millions)

Figure 21. Middle East & Africa Tumor Immunotherapy Market Size 2017-2022 ($ Millions)

Figure 22. Americas Tumor Immunotherapy Value Market Share by Country in 2021

Figure 23. Americas Tumor Immunotherapy Consumption Market Share by Type in 2021

Figure 24. Americas Tumor Immunotherapy Market Size Market Share by Application in 2021

Figure 25. United States Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 26. Canada Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 27. Mexico Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 28. Brazil Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 29. APAC Tumor Immunotherapy Market Size Market Share by Region in 2021

Figure 30. APAC Tumor Immunotherapy Market Size Market Share by Application in 2021

Figure 31. China Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 32. Japan Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 33. Korea Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 34. Southeast Asia Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 35. India Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 36. Australia Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 37. Europe Tumor Immunotherapy Market Size Market Share by Country in 2021

Figure 38. Europe Tumor Immunotherapy Market Size Market Share by Type in 2021

Figure 39. Europe Tumor Immunotherapy Market Size Market Share by Application in 2021

Figure 40. Germany Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 41. France Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 42. UK Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 43. Italy Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 44. Russia Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 45. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Region in 2021

Figure 46. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Type in 2021

Figure 47. Middle East & Africa Tumor Immunotherapy Market Size Market Share by Application in 2021

Figure 48. Egypt Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 49. South Africa Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 50. Israel Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 51. Turkey Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 52. GCC Country Tumor Immunotherapy Market Size Growth 2017-2022 ($ Millions)

Figure 53. Americas Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 54. APAC Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 55. Europe Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 56. Middle East & Africa Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 57. United States Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 58. Canada Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 59. Mexico Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 60. Brazil Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 61. China Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 62. Japan Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 63. Korea Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 64. Southeast Asia Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 65. India Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 66. Australia Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 67. Germany Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 68. France Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 69. UK Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 70. Italy Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 71. Russia Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 72. Spain Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 73. Egypt Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 74. South Africa Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 75. Israel Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 76. Turkey Tumor Immunotherapy Market Size 2023-2028 ($ Millions)

Figure 77. GCC Countries Tumor Immunotherapy Market Size 2023-2028 ($ Millions)